New Delhi, Oct. 22 -- Gujarat-based pharma major, Torrent Pharmaceuticals, on Tuesday, 21 October 2025, received the approval from India's antitrust regulator, the Competition Commission of India (CCI), to acquire a majority stake in KKR-backed JB Chemicals.

According to an exchange filing, CCI approved the majority stake acquisition move, provided the parties comply with the voluntary modifications, which will be outlined in the regulator's final order.

"This is to inform you that the Competition Commission of India (CCI) has granted its approval for the transaction on 21st October, 2025, subject to the parties complying with voluntary modifications to be outlined in CCI's final order," the company informed the stock exchanges through ...